Prucalopride Basic Facts:
- Brand name Resolor - developed by Movetis.
- New drug for treatment of constipation.
- Acts as a selective, high affinity 5-HT4 receptor agonist.
- Targets the impaired motility associated with chronic constipation - leading to a normalisation of bowel movements.
- Indicated for symptomatic treatment of chronic constipation in women in whom laxatives fail to provide adequate relief.
- Median time to the first spontaneous bowel movement is 2 1/2 hours.
Actions:
- First in class dihydrobenzofurancarboxamide.
- Selective, high affinity serotonin (5-HT4) receptor agonist.
- Prucalopride alters colonic motility patterns via serotonin 5-HT4 receptor stimulation.
- The 5-HT4 receptor stimulation induces colonic mass movements.
- Prucalopride has >150-fold higher affinity for 5-HT4 receptors than for other receptors - differentiating it from tegaserod & cisapride.
Pharmacokinetics:
- Prucalopride is rapidly absorbed & extensively distributed.
- Elimination is mainly unchanged in the urine.
- The renal excretion of unchanged prucalopride involves both passive filtration & also active secretion.
- Plasma clearance averages 317 ml/min.
- Terminal half-life is 24–30 hours.
- Steady-state drug concentrations are reached within 3–4 days.
Dosing:
- 2 mg once daily.
- Exceeding the daily dose of 2 mg is not expected to increase efficacy.
Drug Interactions:
- Low interaction potential.
- Therapeutic concentrations of prucalopride do not affect the CYP-mediated metabolism of drugs.
Side Effects:
- Most common are headache & gastrointestinal symptoms.
- GI symptoms - Abdominal pain, diarrhoea, nausea - about 20% patients.
- These effects occur mostly at the start of therapy and tend to disappear within a few days.
- Prucalopride has no significant effect on QT interval.
Tags: 5-HT4 receptor antagonist - Constipation - Prucalopride - Resolor - Serotonin
Posted by Medicalchemy
Medicalchemy Group: History of Medicine - Images - Mnemonics - Syndromes - Acute Medicine - Anaesthesiology - Anatomy - Anthropology - Biochemistry - Cardiology - Dentistry - Dermatology - Drug ADR - Drugs - Embryology - Emergency Medicine - Endocrinology - Epidemiology - Family Medicine - Forensic Medicine - Gastroenterology - Genes - Genetics - Geriatrics - Gynecology - Haematology - Health Informatics - Hepatology - Immunology - Infection - Intensive Care - Medical Dictionary - Medical Education - Medical Statistics - Metabolic Medicine - Microbiology - Nephrology - Neuroanatomy - Neuroscience - Nuclear Medicine - Nutrition - Obstetrics - Occupational Health - Oncology - Ophthalmology - Orthopaedics - Otolaryngology - Paediatrics - Palliative Care - Parasitology - Pathology - Pharmacology - Physiology - Proteomics - Psychiatry - Public Health - Radiology - Respiratory - Rehabilitation - Rheumatology - Sports Medicine - Surgery - Toxicology - Tropical Medicine - Urology - Vascular - Virology.
Posted by Medicalchemy
Medicalchemy Group: History of Medicine - Images - Mnemonics - Syndromes - Acute Medicine - Anaesthesiology - Anatomy - Anthropology - Biochemistry - Cardiology - Dentistry - Dermatology - Drug ADR - Drugs - Embryology - Emergency Medicine - Endocrinology - Epidemiology - Family Medicine - Forensic Medicine - Gastroenterology - Genes - Genetics - Geriatrics - Gynecology - Haematology - Health Informatics - Hepatology - Immunology - Infection - Intensive Care - Medical Dictionary - Medical Education - Medical Statistics - Metabolic Medicine - Microbiology - Nephrology - Neuroanatomy - Neuroscience - Nuclear Medicine - Nutrition - Obstetrics - Occupational Health - Oncology - Ophthalmology - Orthopaedics - Otolaryngology - Paediatrics - Palliative Care - Parasitology - Pathology - Pharmacology - Physiology - Proteomics - Psychiatry - Public Health - Radiology - Respiratory - Rehabilitation - Rheumatology - Sports Medicine - Surgery - Toxicology - Tropical Medicine - Urology - Vascular - Virology.
No comments:
Post a Comment